71 related articles for article (PubMed ID: 1475045)
1. In situ DNA-protein binding: a novel method for detecting DNA-binding activity of transcription factor in brain.
Wang XB; Watanabe Y; Osugi T; Ikemoto M; Hirata M; Miki N
Neurosci Lett; 1992 Oct; 146(1):25-8. PubMed ID: 1475045
[TBL] [Abstract][Full Text] [Related]
2. Nectin-2 expression in testicular cells is controlled via the functional cooperation between transcription factors of the Sp1, CREB, and AP-1 families.
Lui WY; Sze KL; Lee WM
J Cell Physiol; 2006 Apr; 207(1):144-57. PubMed ID: 16250013
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological regulation of AP-1 transcription factor DNA binding activity.
Pennypacker KR; Hong JS; McMillian MK
FASEB J; 1994 May; 8(8):475-8. PubMed ID: 8181665
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine activates DNA binding of specific redox-responsive transcription factors in mouse brain.
Lee YW; Son KW; Flora G; Hennig B; Nath A; Toborek M
J Neurosci Res; 2002 Oct; 70(1):82-9. PubMed ID: 12237866
[TBL] [Abstract][Full Text] [Related]
5. Effect of intra-ischemic hypothermia on the expression of c-Fos and c-Jun, and DNA binding activity of AP-1 after focal cerebral ischemia in rat brain.
Akaji K; Suga S; Fujino T; Mayanagi K; Inamasu J; Horiguchi T; Sato S; Kawase T
Brain Res; 2003 Jun; 975(1-2):149-57. PubMed ID: 12763603
[TBL] [Abstract][Full Text] [Related]
6. Cloning and functional characterization of the 5' flanking region of the human mitochondrial malic enzyme gene. Regulatory role of Sp1 and AP-2.
Butta N; González-Manchón C; Arias-Salgado EG; Ayuso MS; Parrilla R
Eur J Biochem; 2001 May; 268(10):3017-27. PubMed ID: 11358520
[TBL] [Abstract][Full Text] [Related]
7. DNA-binding activity of Jun is increased through its interaction with Fos.
Allegretto EA; Smeal T; Angel P; Spiegelman BM; Karin M
J Cell Biochem; 1990 Apr; 42(4):193-206. PubMed ID: 2111328
[TBL] [Abstract][Full Text] [Related]
8. Polyamine depletion is associated with an increase in JunD/AP-1 activity in small intestinal crypt cells.
Patel AR; Wang JY
Am J Physiol; 1999 Feb; 276(2):G441-50. PubMed ID: 9950818
[TBL] [Abstract][Full Text] [Related]
9. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
Ramirez-Carrozzi VR; Kerppola TK
J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
11. Loss of transcription factor AP-1 DNA binding activity during lymphocyte aging in vivo.
Sikora E; Kamińska B; Radziszewska E; Kaczmarek L
FEBS Lett; 1992 Nov; 312(2-3):179-82. PubMed ID: 1426249
[TBL] [Abstract][Full Text] [Related]
12. Functional interaction between c-Jun and promoter factor Sp1 in epidermal growth factor-induced gene expression of human 12(S)-lipoxygenase.
Chen BK; Chang WC
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10406-11. PubMed ID: 10973489
[TBL] [Abstract][Full Text] [Related]
13. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of DNA bending and oriented heterodimer binding by the basic leucine zipper domains of Fos and Jun.
Leonard DA; Rajaram N; Kerppola TK
Proc Natl Acad Sci U S A; 1997 May; 94(10):4913-8. PubMed ID: 9144164
[TBL] [Abstract][Full Text] [Related]
15. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins.
Kataoka K; Noda M; Nishizawa M
Oncogene; 1996 Jan; 12(1):53-62. PubMed ID: 8552399
[TBL] [Abstract][Full Text] [Related]
16. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins.
Rutberg SE; Saez E; Glick A; Dlugosz AA; Spiegelman BM; Yuspa SH
Oncogene; 1996 Jul; 13(1):167-76. PubMed ID: 8700543
[TBL] [Abstract][Full Text] [Related]
18. The alpha2 and alpha5 integrin genes: identification of transcription factors that regulate promoter activity in epidermal keratinocytes.
Corbi AL; Jensen UB; Watt FM
FEBS Lett; 2000 Jun; 474(2-3):201-7. PubMed ID: 10838085
[TBL] [Abstract][Full Text] [Related]
19. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
20. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer.
De Cesare D; Vallone D; Caracciolo A; Sassone-Corsi P; Nerlov C; Verde P
Oncogene; 1995 Jul; 11(2):365-76. PubMed ID: 7624151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
